DBV Technologies | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amarin USD 42.3M 25.19M 2024-09
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
DBV Technologies USD 560K 512K 2024-12
Halozyme Therapeutics USD 265M 33.01M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 92.82M 11.62M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
United Therapeutics USD 794.4M 58.5M 2025-03



DBV Technologies Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.